Digital Healthcare Technology / Pharmaceutical Marketing Technology
Strategic Profile
The platform combines innovative, AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood® audiences to deliver timely, relevant, and hyper-local engagement. Broader client base and scalable SaaS contracts increase earnings stability and margin expansion, while rapid scaling of high-margin subscription offerings and AI-driven tools positions the company for outsized, sustained profitability with expanding margins and financial discipline supporting long-term growth above industry averages.
Cyborg Score Rationale
Gross profit rose 59% to $18.6 million, while Adjusted EBITDA reached $5.8 million. In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year. According to 3 analysts, the average rating is 'Buy' with a 12-month stock price target of $19.67, representing an 80.62% upside.
Top Insights
OptimizeRx announced four new partner agreements in December 2025 that expand its point-of-care network and deepen exclusivity with key platforms.
OptimizeRx announced a data collaboration with Experian in January 2026 to map Micro-Neighborhood® audiences to Experian's identity graph, enabling deterministic onboarding and improved audience quality in privacy-safe DTC healthcare marketing.
Q3 2025 guidance increased to revenue range between $105-109 million with 2026 guidance of $118-124 million, indicating strong growth trajectory.
By bridging the gap between HCP and direct-to-consumer (DTC) strategies, OptimizeRx empowers brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.
Named Competitors
Digital Healthcare Engagement Platform — Private equity-backed healthcare technology provider
Recent Developments
(March 2026) Q4 2025 earnings conference call scheduled for March 5, 2026 to discuss full-year 2025 results
(January 2026) Strategic data collaboration with Experian to integrate Micro-Neighborhood® audiences with identity graph
(December 2025) Four new partner agreements announced expanding in-workflow point-of-care network and platform exclusivity
Open the full interactive OptimizeRx Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.